This effect was common to the chronic myeloid leukemia K562 cell line, also resistant to UNBS1450 and exhibiting high levels of expression of BCL2L1 (Fig. 4A–C and Supplementary Fig. S9A–C). Here, BCL2L1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.